William Pridgen is Director at Virios Therapeutics, Inc. (VIRI). They have made 10 open-market trades across 1 company since 2020, most recently 2023-08-21.
CIK 0001826115
10 open-market purchases totalling $232K since 2020, never a sale. Across 10 scored buys the stock is down 13.1% at ninety days, and 12.5 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VIRI | 52,045 | $8K |
Shares reported on the most recent Form 4, priced at the 2023-08-22 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 20% | 20% |
| Avg Move | -4.4% | -10.6% | -13.1% |
| Alpha | -5.9% | -6.9% | -12.5% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIRI | BUY | 2023-08-21 | 2023-08-22 | $1.30 | $20K | -12.4% | -27.1% | -43.2% |
| VIRI | BUY | 2022-05-18 | 2022-05-19 | $4.50 | $1K | -10.3% | -12.6% | +23.0% |
| VIRI | BUY | 2022-05-17 | 2022-05-18 | $4.38 | $59K | -2.4% | -11.7% | +52.7% |
| VIRI | BUY | 2022-03-29 | 2022-03-30 | $4.94 | $3K | -3.9% | -12.8% | -11.1% |
| VIRI | BUY | 2022-03-23 | 2022-03-24 | $5.46 | $12K | -11.3% | -20.9% | -20.3% |
| VIRI | BUY | 2022-01-27 | 2022-01-28 | $5.98 | $25K | +0.2% | -12.0% | -40.0% |
| VIRI | BUY | 2022-01-03 | 2022-01-04 | $5.43 | $12K | +12.2% | +11.1% | -16.8% |
| VIRI | BUY | 2021-12-21 | 2021-12-22 | $5.66 | $50K | +0.5% | +15.7% | -3.0% |
| VIRI | BUY | 2021-07-07 | 2021-07-09 | $6.32 | $6K | -8.6% | -15.1% | -22.0% |
| VIRI | BUY | 2021-01-29 | 2021-02-01 | $7.47 | $26K | +7.9% | -16.0% | -28.4% |
| VIRI | BUY | 2020-12-17 | 2020-12-21 | $11.98 | $18K | -24.1% | -19.8% | -43.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.